Pulse Biosciences, Inc. PLSE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s accrued expenses?
- Pulse Biosciences, Inc. (PLSE) reported accrued expenses of $5.41M in Q1 2026.
- How has Pulse Biosciences, Inc.'s accrued expenses changed year-over-year?
- Pulse Biosciences, Inc.'s accrued expenses increased by 35.7% year-over-year, from $3.98M to $5.41M.
- What is the long-term trend for Pulse Biosciences, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s accrued expenses has grown at a 1.5% compound annual growth rate (CAGR), from $3.32M to $3.58M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.